IP Library Assignment 070585/0061
Patent Assignment
Reel/Frame 070585/0061

Assignment of Assignor's Interest

Recorded: 2025-03-20 Pages: 19
Assignor
BIORA THERAPEUTICS, INC.
Executed: 2025-03-07
Assignee
BT BIDCO, INC.
10070 CARROLL CANYON ROAD, #100, SAN DIEGO, CALIFORNIA, 92131
Covered Properties (141)
Ingestible Medical Device
Application: 61/600,029 →
Electromechanical Pill Device with Localization Capabilities
Application: 62/055,244 →
Electromechanical Pill Device with Localization Capabilities
Application: 18/766,498 →
Publication: US US20240358273A1
Sampling Systems and Related Materials and Methods
Application: 16/787,557 →
Publication: US US20200170627A1
Compositions, Methods, and Devices for Bacteria Detection and Quantitation
Application: 62/431,297 →
Ingestible Device Recovery System
Application: 62/434,188 →
Ingestible Device and Associated Methods
Application: 62/434,797 →
Ingestible Device and Associated Methods
Application: 62/570,411 →
Ingestible Device and Associated Methods
Application: 17/745,549 →
Publication: US US20220273196A1
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/434,363 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/479,118 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/545,240 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/583,768 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 16/465,360 →
Publication: US US20190343425A1
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/434,348 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/478,744 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/545,188 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/583,797 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Application: 18/174,603 →
Publication: US US20250230229A1
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/434,369 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/478,863 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/545,220 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/583,804 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 16/467,744 →
Publication: US US20200253506A1
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application: 62/434,366 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application: 62/478,840 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application: 62/545,219 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application: 62/583,800 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Application: 17/864,319 →
Publication: US US20230019619A1
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application: 62/434,371 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application: 62/478,846 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application: 62/545,311 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application: 62/583,823 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/434,374 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/478,919 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/545,380 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/583,832 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Application: 18/384,378 →
Publication: US US20240252425A1
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 62/434,372 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 62/478,937 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 62/545,157 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 62/583,861 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 18/959,485 →
Publication: US US20250082265A1
Localization Systems and Methods for an Optoelectromechanical Pill Device
Application: 62/480,187 →
Localization Systems and Methods for an Ingestible Device
Application: 62/540,873 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application: 62/507,008 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application: 62/545,232 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application: 62/583,806 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application: 62/598,957 →
Treatment of a Disease of the Gastrointestinal Tract with a CD40/CD40L Inhibitor
Application: 62/545,129 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application: 62/583,921 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application: 62/598,966 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent Released Using an Ingestible Device
Application: 18/403,636 →
Publication: US US20240335644A1
Gastrointestinal Tract Detection Methods, Devices and Systems
Application: 18/826,061 →
Publication: US US20250000364A1
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Application: 62/583,929 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application: 62/622,639 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application: 62/650,850 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application: 62/687,683 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application: 16/964,281 →
Publication: US US20210031012A1
Ingestible Device with Relatively Large Payload Volume
Application: 62/642,544 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application: 62/679,659 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application: 62/751,209 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application: 62/829,225 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application: 17/059,058 →
Publication: US US20210386367A1
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application: 62/687,697 →
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application: 16/769,983 →
Publication: US US20220135666A1
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/687,429 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 62/804,828 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application: 17/253,811 →
Publication: US US20230312700A1
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/687,745 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 62/804,840 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application: 17/253,802 →
Publication: US US20210363233A1
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/687,546 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/786,275 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 62/805,099 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application: 17/253,806 →
Publication: US US20230033021A1
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/687,756 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application: 62/804,385 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Application: 19/001,302 →
Publication: US 2026/0014156
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 62/687,751 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunomodulator
Application: 17/253,799 →
Publication: US US20230041197A1
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application: 62/687,766 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application: 19/041,919 →
Publication: US US20260001946A1
Methods of Treating and Predicting Non-response to Anti-TNF Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application: 63/104,399 →
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application: 63/182,678 →
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with Gastrointestinal Tract Diseases
Application: 18/250,202 →
Publication: US US20250325662A1
Aqueous Formulations of Tofacitinib and Tofacitinib Salts
Application: 63/242,436 →
Aqueous Formulations of Tofacitinib and Tofacitinib Salts
Application: 18/578,472 →
Publication: US US20240299295A1
Ingestible Devices and Related Systems and Methods
Application: 62/560,618 →
Ingestible Medical Device
Application: 14/460,893 →
Publication: US US20150011874A1
Electromechanical Pill Device with Localization Capabilities
Application: 15/514,413 →
Publication: US US20170296092A1
Electromechanical Pill Device with Localization Capabilities
Application: 17/030,533 →
Publication: US US20210015398A1
Sampling Systems and Related Materials and Methods
Application: 15/680,430 →
Publication: US US20180052084A1
Methods for Collecting and Testing Bacteria Containing Samples from Within the Gastrointestinal Tract
Application: 17/197,125 →
Publication: US US20210196127A1
Ingestible Device Recovery System
Application: 16/464,739 →
Publication: US US20190307434A1
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Application: 16/465,632 →
Publication: US US20200262908A1
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Application: 16/467,784 →
Publication: US US20190321613A1
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application: 16/466,134 →
Publication: US US20200205729A1
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Application: 16/468,158 →
Publication: US US20200197295A1
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Application: 17/313,339 →
Publication: US US20220105026A1
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 16/468,917 →
Publication: US US20220071559A1
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application: 17/978,077 →
Publication: US US20230309917A1
Localization Systems and Methods for an Ingestible Device
Application: 15/940,407 →
Publication: US US20180279908A1
Localization Systems and Methods for an Ingestible Device
Application: 17/751,352 →
Publication: US US20220322961A1
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application: 16/497,117 →
Publication: US US20210121533A1
Gastrointestinal Tract Detection Methods, Devices and Systems
Application: 15/835,303 →
Publication: US US20180206769A1
Gastrointestinal Tract Detection Methods, Devices and Systems
Application: 16/827,807 →
Publication: US US20200221954A1
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Application: 16/465,803 →
Publication: US US20200170937A1
Ingestible Device and Associated Methods
Application: 15/844,427 →
Publication: US US20180168490A1
Ingestible Device With Relatively Large Payload Volume
Application: 16/299,537 →
Publication: US US20190282791A1
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Application: 17/253,807 →
Publication: US US20220257600A1
Method of Formulating a Pharmaceutical Composition Comprising Administering an Immune Modulator to the Intestine
Application: 17/253,804 →
Publication: US US20230009902A1
Electromechanical Pill Device with Localization Capabilities
Sampling Systems and Related Materials and Methods
Gastrointestinal Tract Detection Methods, Devices and Systems
Ingestible Device Recovery System
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Localization Systems and Methods for an Ingestible Device
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Gastrointestinal Tract Detection Methods, Devices and Systems
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Ingestible Device and Associated Methods
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Ingestible Device with Relatively Large Payload Volume
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Immunomodulator
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with a Disease of the Gastrointestinal Tract
Aqueous Formulations of Tofactinib and Tofacitinib Salts
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 22, 2012
From: AMOAKO-TUFFOUR, YAW; JONES, MITCHELL; PRAKASH, SATYA
To: MICROPHARMA LIMITED
Reel/Frame 028245/0392 →
Assignment of Assignor's Interest Oct 30, 2014
From: JONES, MITCHELL LAWRENCE; LABBÉ, ALAIN; DRLIK, MARK SASHA; PROCH MCMECHAN, CHRISTIAN TERRY
To: MICROPHARMA LIMITED
Reel/Frame 034071/0606 →
Assignment of Assignor's Interest Jun 12, 2015
From: MICROPHARMA LIMITED
To: INTERFACE THERAPEUTICS, INC.
Reel/Frame 035903/0232 →
Assignment of Assignor's Interest Jun 30, 2015
From: INTERFACE THERAPEUTICS, INC.
To: PROGENITY, INC.
Reel/Frame 035942/0510 →
Assignment of Assignor's Interest Apr 3, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 041831/0263 →
Assignment of Assignor's Interest May 8, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042278/0313 →
Assignment of Assignor's Interest May 8, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042421/0265 →
Assignment of Assignor's Interest May 8, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042280/0664 →
Assignment of Assignor's Interest May 8, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042278/0815 →
Assignment of Assignor's Interest May 8, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042278/0553 →
Assignment of Assignor's Interest May 9, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042304/0511 →
Assignment of Assignor's Interest May 9, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042304/0322 →
Assignment of Assignor's Interest May 9, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042303/0510 →
Assignment of Assignor's Interest May 9, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042307/0131 →
Assignment of Assignor's Interest May 9, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042306/0966 →
Assignment of Assignor's Interest May 9, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042306/0859 →
Assignment of Assignor's Interest May 9, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042305/0931 →
Assignment of Assignor's Interest May 10, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042321/0491 →
Assignment of Assignor's Interest May 10, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042321/0269 →
Assignment of Assignor's Interest Jul 11, 2017
From: GREEN, JASON; HOPKINS, MARIA; JONES, BENJAMIN; KIRYANOV, ANDRE A.
To: TAKEDA CALIFORNIA, INC.
Reel/Frame 042979/0545 →
Assignment of Assignor's Interest Jul 11, 2017
From: TAKEDA CALIFORNIA, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 042979/0564 →
Assignment of Assignor's Interest Nov 16, 2017
From: JONES, RYAN ELLIOTT; TANG, HAMILTON ROGER; GERVER, RACHEL ELLEN
To: PROGENITY INC.
Reel/Frame 044155/0067 →
Assignment of Assignor's Interest Nov 30, 2017
From: SINGH, SHARAT
To: PROGENITY INC.
Reel/Frame 044264/0841 →
Assignment of Assignor's Interest May 31, 2018
From: SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 045950/0689 →
Assignment of Assignor's Interest Jun 5, 2019
From: JONES, RYAN ELLIOTT; TANG, HAMILTON ROGER; GERVER, RACHEL ELLEN; JONES, MITCHELL LAWRENCE
To: PROGENITY, INC.
Reel/Frame 049375/0041 →